Trump decides to demand lower drug prices under Medicare
You’re reading the web edition of DC Diagnosis, STAT’s biweekly newsletter on health and medicine policy and politics. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
The NIH director started the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya doing pull-ups. And you can decide what you think of these pumps. Send training tips and advice to [email protected] or John_Wilkerson.07 on Signal. I will see you again in the new year. This newsletter is on break for the holidays.
Trump’s Favorite Drug Pricing Policy
Since his first term, Trump has promised to lower U.S. drug prices to levels in other wealthy countries. On Friday, the administration announced most favored nation agreements with nine other drugmakers. CMS then proposed two mandatory MFN pilot programs in Medicare.
This article is reserved for STAT+ subscribers
Unlock this article, plus in-depth analysis, newsletters, premium events and news alerts.
Already have an account? Log in
See all packages
Firm Law
Agen Togel Terpercaya
Bandar Togel
Sabung Ayam Online
Berita Terkini
Artikel Terbaru
Berita Terbaru
Penerbangan
Berita Politik
Berita Politik
Software
Software Download
Download Aplikasi
Berita Terkini
News
Jasa PBN
Jasa Artikel